Dermal Irritation, Sensitization, and Safety of Fixed-Dose Triple-Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.1%/Adapalene 0.15% Gel in Healthy Participants

被引：0
|
作者：
Draelos, Zoe [1 ]
Tanghetti, Emil [2 ]
Gold, Linda Stein [3 ]
Kircik, Leon [4 ]
Bhatia, Neal [5 ]
Zeichner, Joshua [4 ]
Sugarman, Jeffrey [6 ]
机构：
[1] Dermatol Consulting Serv PLLC, High Point, NC USA
[2] Ctr Dermatol & Laser Surg, High Point, NC USA
[3] Henry Ford Hosp, Detroit, MI USA
[4] Icahn Sch Med Mt Sinai, New York, NY USA
[5] Therapeut Clin Res, New York, NY USA
[6] Univ Calif San Francisco, San Francisco, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43390
引用
收藏
页码：AB33 / AB33
页数：1
相关论文
共 50 条
  • [41] Treatment of acne and acne-related scarring with fixed combination clindamycin phosphate and benzoyl peroxide gel (1.2%/3.75%) and tretinoin gel microsphere 0.06% in an Asian American transgender female
    Kaminska, Edidiong C. N.
    SAGE OPEN MEDICAL CASE REPORTS, 2020, 8
  • [42] Managing moderate to severe acne in adolescents: Benefits of a fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in a subpopulation of 1755 subjects
    Cook-Bolden, Fran
    Chen, Diana
    Eichenfield, Lawrence
    Stein-Gold, Linda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB22 - AB22
  • [43] Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients
    Gollnick, H. P. M.
    Draelos, Z.
    Glenn, M. J.
    Rosoph, L. A.
    Kaszuba, A.
    Cornelison, R.
    Gore, B.
    Liu, Y.
    Graeber, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) : 1180 - 1189
  • [44] Clindamycin phosphate 1.2%-benzoyl peroxide 3.0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study
    Kawashima, M.
    Hashimoto, H.
    Saenz, A. B. Alio
    Ono, M.
    Yamada, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (02) : 494 - 503
  • [45] Systemic Exposure to Benzoic Acid and Hippuric Acid Following Topical Application of Clindamycin 1%/Benzoyl Peroxide 3% Fixed-Dose Combination Gel in Japanese Patients with Acne Vulgaris
    Ino, Hiroko
    Takahashi, Naoki
    Saenz, Alessandra Alio
    Wakamatsu, Akira
    Hashimoto, Hirofumi
    Nakahara, Norie
    Hasegawa, Setsuo
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (01): : 18 - 24
  • [46] Patient-reported outcomes using a fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel for the treatment of moderate to severe acne in 2813 subjects
    Weiss, Jonathan
    Fowler, Joseph
    Yu, Karen
    Swinyer, Leonard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB18 - AB18
  • [47] Efficacy of a once-daily fixed combination clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel across a broad patient population with moderate to severe acne
    Stein-Gold, Linda
    Chen, Diana
    Cook-Bolden, Fran
    Baldwin, Hilary
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (03) : AB15 - AB15
  • [48] Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1% and Clindamycin 1% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial
    Luan, Chao
    Yang, Wen Lin
    Yin, Jia Wen
    Deng, Lie Hua
    Chen, Bin
    Liu, Hong Wei
    Zhang, Shou Min
    Han, Jian De
    Liu, Zhi Jun
    Dai, Xiang Rong
    Yin, Qiu Ju
    Yu, Xiao Hui
    Chen, Kun
    Gu, Heng
    Li, Benjamin Xiao Yi
    DERMATOLOGY AND THERAPY, 2024, 14 (11) : 3097 - 3112
  • [49] Multicenter study for efficacy and safety evaluation of a fixed-dose combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo®) for the treatment of acne vulgaris in Brazilian population
    de Souza Sittart, Jose Alexandre
    da Costa, Adilson
    Mulinari-Brenner, Fabiane
    Follador, Ivonise
    Azulay-Abulafia, Luna
    Miranda de Castro, Lia Candida
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2015, 90 (06) : 6 - 15
  • [50] Effective and Safe Combination Therapy for Severe Acne Vulgaris: A Randomized, Vehicle-Controlled, Double.-blind Study of Adapalene 0.1%-Benzoyl Peroxide 2.5% Fixed-Dose Combination Gel With Doxycycline Hyclate 100 mg
    Gold, Linda Stein
    Cruz, Alma
    Eichenfield, Lawrence
    Tan, Jerry
    Jorizzo, Joseph
    Kerrouche, Nabil
    Dhuin, Jean-Charles
    CUTIS, 2010, 85 (02): : 94 - 104
12345